
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney
Magen E. Francis, Una Goncin, Andrea Kroeker, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 7, pp. e1009705-e1009705
Open Access | Times Cited: 82
Magen E. Francis, Una Goncin, Andrea Kroeker, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 7, pp. e1009705-e1009705
Open Access | Times Cited: 82
Showing 26-50 of 82 citing articles:
Phenotyping the virulence of SARS-CoV-2 variants in hamsters by digital pathology and machine learning
Gavin R. Meehan, Vanessa Herder, Jay Allan, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011589-e1011589
Open Access | Times Cited: 9
Gavin R. Meehan, Vanessa Herder, Jay Allan, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 11, pp. e1011589-e1011589
Open Access | Times Cited: 9
Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters
Rakesh Kulkarni, Wen-Ching Chen, Ying Lee, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0257191-e0257191
Open Access | Times Cited: 21
Rakesh Kulkarni, Wen-Ching Chen, Ying Lee, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0257191-e0257191
Open Access | Times Cited: 21
Development of Monoclonal Antibody 281-mG2a-f Against Golden Hamster Podoplanin
Ren Nanamiya, Hiroyuki Suzuki, Junko Takei, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2022) Vol. 41, Iss. 6, pp. 311-319
Closed Access | Times Cited: 15
Ren Nanamiya, Hiroyuki Suzuki, Junko Takei, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2022) Vol. 41, Iss. 6, pp. 311-319
Closed Access | Times Cited: 15
Compellingly high SARS-CoV-2 susceptibility of Golden Syrian hamsters suggests multiple zoonotic infections of pet hamsters during the COVID-19 pandemic
Claudia Blaurock, Angele Breithaupt, Saskia Weber, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Claudia Blaurock, Angele Breithaupt, Saskia Weber, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Efficacy of a stable broadly protective subunit vaccine platform against SARS-CoV-2 variants of concern
Ravendra Garg, Qiang Liu, Jill van Kessel, et al.
Vaccine (2024) Vol. 42, Iss. 20, pp. 125980-125980
Open Access | Times Cited: 2
Ravendra Garg, Qiang Liu, Jill van Kessel, et al.
Vaccine (2024) Vol. 42, Iss. 20, pp. 125980-125980
Open Access | Times Cited: 2
Discovery of potential anti-SARS-CoV-2 drugs based on large-scale screening in vitro and effect evaluation in vivo
Haoran Peng, Cui‐Ling Ding, Liangliang Jiang, et al.
Science China Life Sciences (2021) Vol. 65, Iss. 6, pp. 1181-1197
Open Access | Times Cited: 19
Haoran Peng, Cui‐Ling Ding, Liangliang Jiang, et al.
Science China Life Sciences (2021) Vol. 65, Iss. 6, pp. 1181-1197
Open Access | Times Cited: 19
Pharmacological Activities of Fingerroot Extract and Its Phytoconstituents Against SARS-CoV-2 Infection in Golden Syrian Hamsters
Teetat Kongratanapasert, Supasek Kongsomros, Nlin Arya, et al.
Journal of Experimental Pharmacology (2023) Vol. Volume 15, pp. 13-26
Open Access | Times Cited: 6
Teetat Kongratanapasert, Supasek Kongsomros, Nlin Arya, et al.
Journal of Experimental Pharmacology (2023) Vol. Volume 15, pp. 13-26
Open Access | Times Cited: 6
More than a key—the pathological roles of SARS-CoV-2 spike protein in COVID-19 related cardiac injury
Zhiqiang Lin
Sports Medicine and Health Science (2023) Vol. 6, Iss. 3, pp. 209-220
Open Access | Times Cited: 6
Zhiqiang Lin
Sports Medicine and Health Science (2023) Vol. 6, Iss. 3, pp. 209-220
Open Access | Times Cited: 6
Immune–epithelial cell cross‐talk enhances antiviral responsiveness to SARS‐CoV ‐2 in children
Vladimir Gonçalves Magalhães, Soeren Lukassen, Maike Drechsler, et al.
EMBO Reports (2023) Vol. 24, Iss. 12
Open Access | Times Cited: 6
Vladimir Gonçalves Magalhães, Soeren Lukassen, Maike Drechsler, et al.
EMBO Reports (2023) Vol. 24, Iss. 12
Open Access | Times Cited: 6
Cardiovascular Tropism and Sequelae of SARS-CoV-2 Infection
Oleksandr Dmytrenko, Kory J. Lavine
Viruses (2022) Vol. 14, Iss. 6, pp. 1137-1137
Open Access | Times Cited: 10
Oleksandr Dmytrenko, Kory J. Lavine
Viruses (2022) Vol. 14, Iss. 6, pp. 1137-1137
Open Access | Times Cited: 10
Anesthesia and analgesia in laboratory rodents
Paulin Jirkof, Jennie Lofgren
Elsevier eBooks (2023), pp. 287-356
Closed Access | Times Cited: 5
Paulin Jirkof, Jennie Lofgren
Elsevier eBooks (2023), pp. 287-356
Closed Access | Times Cited: 5
Cross protection to SARS-CoV-2 variants in hamsters with naturally-acquired immunity
Saina Beitari, Diana Duque, Jegarubee Bavananthasivam, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Saina Beitari, Diana Duque, Jegarubee Bavananthasivam, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Type I interferon signaling in SARS-CoV-2 associated neurocognitive disorder (SAND): Mapping host-virus interactions to an etiopathogenesis
George D. Vavougios, Gabriel A. de Erausquin, Heather M. Snyder
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 9
George D. Vavougios, Gabriel A. de Erausquin, Heather M. Snyder
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 9
Distribution and suitability of pulmonary surfactants as a vehicle for topically applied antibodies in healthy and SARS-CoV-2 infected rodent lungs
Lea-Adriana Barlang, Isabelle Deimel, Björn-Patrick Mohl, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 196, pp. 106744-106744
Open Access | Times Cited: 1
Lea-Adriana Barlang, Isabelle Deimel, Björn-Patrick Mohl, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 196, pp. 106744-106744
Open Access | Times Cited: 1
Efficacy of a Stable Broadly Protective Subunit Vaccine Platform Against Sars-Cov-2 Variants of Concern
Ravendra Garg, Qiang Liu, Jill van Kessel, et al.
(2024)
Closed Access | Times Cited: 1
Ravendra Garg, Qiang Liu, Jill van Kessel, et al.
(2024)
Closed Access | Times Cited: 1
Evaluating Molecular Mechanism of Viral Inhibition of Aerosolized Smart Nano-Enabled Antiviral Therapeutic (SNAT) on SARS-CoV-2-Infected Hamsters
Anais N. Bauer, John F. Williams, Lok R. Pokhrel, et al.
Toxics (2024) Vol. 12, Iss. 7, pp. 495-495
Open Access | Times Cited: 1
Anais N. Bauer, John F. Williams, Lok R. Pokhrel, et al.
Toxics (2024) Vol. 12, Iss. 7, pp. 495-495
Open Access | Times Cited: 1
Persistent alveolar bronchiolization, interstitial fibrosis and impaired lung function post-exercise are features of long-COVID in SARS-CoV-2-Delta variant infected aged hamsters
Wolfgang Baumgärtner, L. Heydemann, Małgorzata Ciurkiewicz, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Wolfgang Baumgärtner, L. Heydemann, Małgorzata Ciurkiewicz, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
SARS-CoV-2 Infects Peripheral and Central Neurons Before Viremia, Facilitated by Neuropilin-1
Jonathan D. Joyce, Greyson A. Moore, Poorna Goswami, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access | Times Cited: 8
Jonathan D. Joyce, Greyson A. Moore, Poorna Goswami, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access | Times Cited: 8
SARS-CoV-2 and the Missing Link of Intermediate Hosts in Viral Emergence - What We Can Learn From Other Betacoronaviruses
Brayden G. Schindell, Meagan Allardice, Jessica A.M. McBride, et al.
Frontiers in Virology (2022) Vol. 2
Open Access | Times Cited: 8
Brayden G. Schindell, Meagan Allardice, Jessica A.M. McBride, et al.
Frontiers in Virology (2022) Vol. 2
Open Access | Times Cited: 8
Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2
Matthew D. Resch, Ke Wen, Ryan Mazboudi, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 1997-1997
Open Access | Times Cited: 8
Matthew D. Resch, Ke Wen, Ryan Mazboudi, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 1997-1997
Open Access | Times Cited: 8
Lipid nanoparticle-encapsulated, chemically modified anti-adenoviral siRNAs inhibit hepatic adenovirus infection in immunosuppressed Syrian hamsters
Anja Geisler, Babette Dieringer, Leslie Elsner, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 923-936
Open Access | Times Cited: 4
Anja Geisler, Babette Dieringer, Leslie Elsner, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 923-936
Open Access | Times Cited: 4
RNA-dependent RNA polymerase of SARS-CoV-2 regulate host mRNA translation efficiency by hijacking eEF1A factors
Haili Gan, Xiaoguang Zhou, Qiong Lei, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 1, pp. 166871-166871
Closed Access | Times Cited: 4
Haili Gan, Xiaoguang Zhou, Qiong Lei, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 1, pp. 166871-166871
Closed Access | Times Cited: 4
Animal models for studying COVID-19, prevention, and therapy: Pathology and disease phenotypes
Shambhunath Choudhary, Isis Kanevsky, Lindsay Tomlinson
Veterinary Pathology (2022) Vol. 59, Iss. 4, pp. 516-527
Open Access | Times Cited: 7
Shambhunath Choudhary, Isis Kanevsky, Lindsay Tomlinson
Veterinary Pathology (2022) Vol. 59, Iss. 4, pp. 516-527
Open Access | Times Cited: 7
Integrating in silico and in vivo approach for investigating the role of polyherbal oil in prevention and treatment of COVID-19 infection
Amul S Bahl, Vipin Verma, Jagriti Bhatia, et al.
Chemico-Biological Interactions (2022) Vol. 367, pp. 110179-110179
Open Access | Times Cited: 7
Amul S Bahl, Vipin Verma, Jagriti Bhatia, et al.
Chemico-Biological Interactions (2022) Vol. 367, pp. 110179-110179
Open Access | Times Cited: 7
Protective Immunity of the Primary SARS-CoV-2 Infection Reduces Disease Severity Post Re-Infection with Delta Variants in Syrian Hamsters
Sreelekshmy Mohandas, Pragya D. Yadav, Anita M. Shete, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 596-596
Open Access | Times Cited: 6
Sreelekshmy Mohandas, Pragya D. Yadav, Anita M. Shete, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 596-596
Open Access | Times Cited: 6